NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The US and Russia failed to reach a deal on Friday as Trump says a permanent peace deal, rather than a ceasefire, is the “best way” to end the war in Ukraine.Read More